Journal
AIDS
Volume 19, Issue 4, Pages 407-411Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/01.aids.0000161770.06158.5c
Keywords
beta-amyloid; HIV; brain; HAART; neurodegeneration
Categories
Funding
- NIAID NIH HHS [U01 AI035040, U01 AI/CA 35040] Funding Source: Medline
- NIA NIH HHS [P50 AG 16570, P50 AG016570] Funding Source: Medline
- NIMH NIH HHS [MH58528] Funding Source: Medline
Ask authors/readers for more resources
Background: We planned to analyze the prevalence and distribution of beta-amyloid deposition in the HIV+ brain in the HAART era. Our working hypothesis is that long term survival, aging and the secondary effects of HAART may contribute to increased beta-amyloid accumulation in this patient population. Methods: Paraffin embedded archival brain autopsy tissues were assessed by immunocytochemistry for beta-amyloid. Detailed in-vivo neuro-behavioral assessments and ApoE genotyping were available for a subset of the studied population. Results: Immunoreactivity with the antibodies 4G8 and 6E10 was found predominantly in neuronal soma and dystrophic axonal processes. Extracellular, often perivascular plaques were also identified in many cases. Conclusions: We propose that prolonged HAART and aging may contribute to an overall increase in amyloid deposition, potentially mediated by inhibition of insulin degradation enzyme (IDE) or disruption of the axonal transport of the amyloid precursor protein. (c) 2005 Lippincott Williams & Wilkins.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available